Session Datesort descending
(Nephrology Hypertension Journal Club) Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis : January 5, 2024 01/05/2024 - 7:30am to 8:30am
(Nephrology Hypertension Journal Club) PHYOX2: a pivotal randomized study of nedosiran in primary hyperoxaluria type 1 or 2 January 12, 2024 01/12/2024 - 7:30am to 8:30am
Nephrology Hypertension Journal Club Multiple infusion of ex vivo-expanded regulatory T cells promote CD163+ myeloid cells and kidney allograft survival in non-lymphodepleted non-human primates : January 19, 2024 01/19/2024 - 7:30am to 8:30am
Nephrology Hypertension Journal Club : Vascular Access-Related Distal Ischemia Requiring Intervention: January 26, 2024 01/26/2024 - 7:30am to 8:30am
Nephrology Hypertension Journal Club Taurolidine/Heparin Lock Solution and Catheter-Related Bloodstream Infection in Hemodialysis - February 2, 2024 02/02/2024 - 7:30am to 8:30am
Nephrology Hypertension Journal Club: VALOR-CKD: A Multicenter, Randomized, Double-Blind Placebo-Controlled Trial Evaluation Veverimer in Slowing Progression of Chronic Kidney Disease in Patients with Metabolic Acidosis : February 23, 2024 02/23/2024 - 7:30am to 8:30am
Nephrology Hypertension Journal Club : Arginine or Hypertonic Saline-Stimulated Copeptin to Diagnose AVP Deficiency : March 1, 2024 03/01/2024 - 7:30am to 8:30am
Nephrology Hypertension Journal Club: Phase 2 Trial of Cemdisiran in Adult Patients with IgA Nephropathy: A Randomized Controlled Trial March 8, 2024 03/08/2024 - 7:30am to 8:30am
Nephrology Hypertension Journal Club Severe Hypocalcemia with Denosumab Among Older Female Dialysis-Dependent Patients March 15 2024 03/15/2024 - 7:30am to 8:30am
Nephrology Hypertension Journal Club Effectiveness of Existing Insomnia Therapies for Patients Undergoing Hemodialysis March 22 2024 03/22/2024 - 7:30am to 8:30am

Pages